Pancreatic Cancer Research

ResearcherVeterans Health AdministrationNo recent work listed

Walter John Curran

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7552-4453; OpenAlex author ID A5026088869. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2013: 1 paper · 2014: 2 papers · 2015: 1 paper

Papers 4

  1. High nuclear hypoxia-inducible factor 1 alpha expression is a predictor of distant recurrence in patients with resected pancreatic adenocarcinoma. Last author DOI 10.1016/j.ijrobp.2014.11.004↗
  2. Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer. Co-author DOI 10.1038/onc.2013.488↗
  3. CHD7 expression predicts survival outcomes in patients with resected pancreatic cancer. Co-author DOI 10.1158/0008-5472.can-13-1996↗
  4. Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma. Co-author DOI 10.1002/cncr.28144↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jerome Carl Landry · 4 shared papers, 2013–2015 · strength 0.14
  2. Lauren Elizabeth Colbert · 4 shared papers, 2013–2015 · strength 0.14
  3. Volkan N. Adsay · 4 shared papers, 2013–2015 · strength 0.14
  4. Burcu Saka · 4 shared papers, 2013–2015 · strength 0.14
  5. Shishir Kumar Maithel · 4 shared papers, 2013–2015 · strength 0.14
  6. Bassel F. El‐Rayes · 4 shared papers, 2013–2015 · strength 0.14
  7. William Adrian Hall · 3 shared papers, 2013–2014 · strength 0.09
  8. David A. Kooby · 3 shared papers, 2013–2014 · strength 0.09
  9. David S. Yu · 3 shared papers, 2013–2014 · strength 0.09
  10. Ganji Purnachandra Nagaraju · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.